Cadila Healthcare Ltd Net Profit is INR 527.2 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Cadila Healthcare Ltd Quarter Net Profit is Up by 41 % from Last Year Quarter and Net Profit of INR 527.2 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020 Net Profit was INR 373.9 crores.
Quarterly Net Sales Year-on-Year
Cadila Healthcare Ltd Quarter Sale is up 4 % from Last Quarter. Sales of 3795.6 is reported in Quarter 3, October – December of Financial Year 2020-2021. In Last Year Quarter 3, October – December of Financial Year 2019-2020 Sale was 3638.1
Annual Sales & Net Earning
Cadila Healthcare Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 13165.6 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR 1848.8 crores.
Cadila Healthcare Ltd Stock Information
|Industry||Pharmaceuticals – Indian – Bulk Drugs & Formln|
|About||Cadila Healthcare is one of the leading, innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovation (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products. Innovation is the backbone of the Company as it ensures business sustainability by ensuring the continuous supply of new products to various businesses.(|
|Latest Qaurter EPS||5.149731489927688|
Cadila Healthcare Ltd Stock Analysis: